Title : Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer.

Pub. Date : 2016 Jan

PMID : 26195282






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 METHODS: Serum amphiregulin levels were quantified in 50 consecutive patients with HER2-positive metastatic breast cancer who received first-line trastuzumab plus taxane chemotherapy between October 2004 and July 2009. taxane amphiregulin Homo sapiens